Insider Transactions last 24 months for Theravance Biopharma, Inc.  -  NSDQ: TBPH

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS03/16/2026DSDirectCOM7,766$13.92$108,073.21232,699
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS03/16/2026DSDirectCOM15,534$14.00$217,476.00240,465
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS03/16/2026DSDirectCOM7,767$13.92$108,087.90255,999
Winningham Rick ECHIEF EXECUTIVE OFFICER02/20/2026DFDirectCOM74,975$19.66$1,474,008.501,576,094
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS02/20/2026DFDirectCOM13,929$19.66$273,844.14263,766
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER02/20/2026DFDirectCOM20,672$19.66$406,411.52316,123
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY02/20/2026DFDirectCOM20,833$19.66$409,576.78334,449
Miller AineSVP, DEV & HEAD OF IRE OFFICE02/20/2026DFDirectCOM16,851$19.66$331,290.66184,161
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS12/03/2025DSDirectCOM15,534$18.75$291,251.63277,695
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS12/03/2025DSDirectCOM7,766$18.75$145,618.71293,229
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS12/03/2025DSDirectCOM7,767$18.75$145,630.47300,995
Broshy EranDirector11/26/2025DSDirectCOM15,501$20.00$310,020.0044,703
Broshy EranDirector11/26/2025DSDirectCOM14,000$20.00$280,000.0060,204
Winningham Rick ECHIEF EXECUTIVE OFFICER11/20/2025DFDirectCOM56,817$17.90$1,017,024.301,651,069
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS11/20/2025DFDirectCOM9,060$17.90$162,174.00308,762
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER11/20/2025DFDirectCOM18,627$17.90$333,423.30336,795
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY11/20/2025DFDirectCOM19,024$17.90$340,529.60355,282
Miller AineSVP, DEV & HEAD OF IRE OFFICE11/20/2025DFDirectCOM6,989$17.90$125,103.10201,012
Winningham Rick ECHIEF EXECUTIVE OFFICER11/19/2025AGIndirectCOM9,900$0.00$0.0023,400
Winningham Rick ECHIEF EXECUTIVE OFFICER11/19/2025DGDirectCOM9,900$0.00$0.001,707,886
Broshy EranDirector11/11/2025DSDirectCOM14,000$18.50$259,000.0046,204
Broshy EranDirector11/11/2025DSDirectCOM15,500$17.00$263,500.0046,204
Broshy EranDirector11/11/2025DSDirectCOM29,500$18.50$545,750.0061,704
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS08/20/2025DFDirectCOM9,096$13.39$121,795.44317,822
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY08/20/2025DFDirectCOM9,762$13.39$130,713.18374,306
1   2  3  4  Next Last  You are at page 1 of 4 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel